Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

IMPORTANCE: Most evidence about efficacy and safety of antipsychotics in schizophrenia spectrum disorders relies on randomized clinical trials (RCTs). However, owing to their strict eligibility criteria, RCTs represent only a part of the real-world population (ie, unselected patients seen in everyda...

Descripción completa

Detalles Bibliográficos
Autores principales: Taipale, Heidi, Schneider-Thoma, Johannes, Pinzón-Espinosa, Justo, Radua, Joaquim, Efthimiou, Orestis, Vinkers, Christiaan H., Mittendorfer-Rutz, Ellenor, Cardoner, Narcís, Pintor, Luis, Tanskanen, Antti, Tomlinson, Anneka, Fusar-Poli, Paolo, Cipriani, Andrea, Vieta, Eduard, Leucht, Stefan, Tiihonen, Jari, Luykx, Jurjen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792792/
https://www.ncbi.nlm.nih.gov/pubmed/35080618
http://dx.doi.org/10.1001/jamapsychiatry.2021.3990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792792/
https://www.ncbi.nlm.nih.gov/pubmed/35080618
http://dx.doi.org/10.1001/jamapsychiatry.2021.3990

Ejemplares similares